OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Simon Dagenais, Leo Russo, Ann Madsen, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 1, pp. 77-89
Open Access | Times Cited: 88
Simon Dagenais, Leo Russo, Ann Madsen, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 1, pp. 77-89
Open Access | Times Cited: 88
Showing 1-25 of 88 citing articles:
Real-World Evidence: A Primer
Amit Dang
Pharmaceutical Medicine (2023) Vol. 37, Iss. 1, pp. 25-36
Open Access | Times Cited: 101
Amit Dang
Pharmaceutical Medicine (2023) Vol. 37, Iss. 1, pp. 25-36
Open Access | Times Cited: 101
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare
Lara Marques, Bárbara Costa, Mariana Pereira, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 332-332
Open Access | Times Cited: 67
Lara Marques, Bárbara Costa, Mariana Pereira, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 332-332
Open Access | Times Cited: 67
Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Susan Gruber, Hana Lee, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 2
Jie Chen, Susan Gruber, Hana Lee, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 2
The impact of commercial health datasets on medical research and health-care algorithms
Isabelle Rose I Alberto, Nicole Rose I. Alberto, Arnab K. Ghosh, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 5, pp. e288-e294
Open Access | Times Cited: 39
Isabelle Rose I Alberto, Nicole Rose I. Alberto, Arnab K. Ghosh, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 5, pp. e288-e294
Open Access | Times Cited: 39
Harnessing artificial intelligence to improve clinical trial design
Bin Zhang, Lu Zhang, Qiuying Chen, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 26
Bin Zhang, Lu Zhang, Qiuying Chen, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 26
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 613-624
Open Access | Times Cited: 10
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 613-624
Open Access | Times Cited: 10
Decision‐Making Criteria and Methods for Initiating Late‐Stage Clinical Trials in Drug Development from a Multi‐Stakeholder Perspective: A Scoping Review
Cheng Jiang, Céline Béji, Sonia Zebachi, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Cheng Jiang, Céline Béji, Sonia Zebachi, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia
Marie‐Laure Charpignon, Bella Vakulenko‐Lagun, Bang Zheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Marie‐Laure Charpignon, Bella Vakulenko‐Lagun, Bang Zheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective
Rui Zhu, Bianca Vora, Sujatha Menon, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 751-767
Open Access | Times Cited: 18
Rui Zhu, Bianca Vora, Sujatha Menon, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 751-767
Open Access | Times Cited: 18
Single-arm clinical trials: design, ethics, principles
Minyan Wang, Huan Ma, Yun Shi, et al.
BMJ Supportive & Palliative Care (2024), pp. spcare-004984
Open Access | Times Cited: 7
Minyan Wang, Huan Ma, Yun Shi, et al.
BMJ Supportive & Palliative Care (2024), pp. spcare-004984
Open Access | Times Cited: 7
Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence
L. N. Z. Nene, Brian Thabile Flepisi, S Brand, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 8, pp. e6-e14
Open Access | Times Cited: 6
L. N. Z. Nene, Brian Thabile Flepisi, S Brand, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 8, pp. e6-e14
Open Access | Times Cited: 6
Role of Disease Progression Models in Drug Development
Jeffrey S. Barrett, Tim Nicholas, Karim Azer, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1803-1815
Open Access | Times Cited: 24
Jeffrey S. Barrett, Tim Nicholas, Karim Azer, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1803-1815
Open Access | Times Cited: 24
Realizing the potential of social determinants data in EHR systems: A scoping review of approaches for screening, linkage, extraction, analysis, and interventions
Chenyu Li, Danielle L. Mowery, Xiaomeng Ma, et al.
Journal of Clinical and Translational Science (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Chenyu Li, Danielle L. Mowery, Xiaomeng Ma, et al.
Journal of Clinical and Translational Science (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Demographic clinical trial diversity assessment methods: Use of real-world data
Hua Chen, Nnadozie Emechebe, Sudeep Karve, et al.
Contemporary Clinical Trials Communications (2025) Vol. 44, pp. 101432-101432
Open Access
Hua Chen, Nnadozie Emechebe, Sudeep Karve, et al.
Contemporary Clinical Trials Communications (2025) Vol. 44, pp. 101432-101432
Open Access
Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database
Stefanie Ho Yi Chan, R Fitzpatrick, Deborah Layton, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 311-311
Open Access
Stefanie Ho Yi Chan, R Fitzpatrick, Deborah Layton, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 311-311
Open Access
Large Language Models for Automating Clinical Trial Criteria Conversion to OMOP CDM Queries: Accuracy and Efficiency Evaluation (Preprint)
Kye Hwa Lee, S.S. Jang, Grace Juyun Kim, et al.
(2025)
Closed Access
Kye Hwa Lee, S.S. Jang, Grace Juyun Kim, et al.
(2025)
Closed Access
Integrating machine learning and human use experience to identify personalized pharmacotherapy in Traditional Chinese Medicine: a case study on resistant hypertension.
Che Qianzi, Dasheng Liu, Xinghua Xiang, et al.
PubMed (2025) Vol. 45, Iss. 1, pp. 192-200
Closed Access
Che Qianzi, Dasheng Liu, Xinghua Xiang, et al.
PubMed (2025) Vol. 45, Iss. 1, pp. 192-200
Closed Access
The relevance of the real-world evidence in research, clinical, and regulatory decision making
Valton Costa, Marcelo Graziano Custodio, Eran Gefen, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Valton Costa, Marcelo Graziano Custodio, Eran Gefen, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment
Veronica Mears, Nikolas Naleid, Omkar Pawar, et al.
JCO Oncology Practice (2025)
Closed Access
Veronica Mears, Nikolas Naleid, Omkar Pawar, et al.
JCO Oncology Practice (2025)
Closed Access
Turning the kaleidoscope: Innovations shaping the future of clinical trial design
Grégoire Marret, Mercedes Herrera, Lillian L. Siu
Cancer Cell (2025)
Closed Access
Grégoire Marret, Mercedes Herrera, Lillian L. Siu
Cancer Cell (2025)
Closed Access
Patient and Public involvement and engagement in real world data and evidence research across the medicines development cycle: a rapid review of peer-reviewed literature and NICE technology appraisals
Sally-Anne Dews, Arisa Oluwatomi, Alex Inskip, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Sally-Anne Dews, Arisa Oluwatomi, Alex Inskip, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
A Holistic Meta-Analysis of AI Implementation in the Pharmaceutical Product Lifecycle
Faizah Mohamad
Lecture notes in networks and systems (2025), pp. 491-508
Closed Access
Faizah Mohamad
Lecture notes in networks and systems (2025), pp. 491-508
Closed Access
Bottom-up and top-down paradigms of artificial intelligence research approaches to healthcare data science using growing real-world big data
Michelle Wang, Madhumita Sushil, Brenda Y. Miao, et al.
Journal of the American Medical Informatics Association (2023) Vol. 30, Iss. 7, pp. 1323-1332
Open Access | Times Cited: 12
Michelle Wang, Madhumita Sushil, Brenda Y. Miao, et al.
Journal of the American Medical Informatics Association (2023) Vol. 30, Iss. 7, pp. 1323-1332
Open Access | Times Cited: 12
Realizing the Potential of Social Determinants Data: A Scoping Review of Approaches for Screening, Linkage, Extraction, Analysis and Interventions
Chenyu Li, Danielle L. Mowery, Xiaomeng Ma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Chenyu Li, Danielle L. Mowery, Xiaomeng Ma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
